Today: 1 May 2026
Coherent stock snaps back after steep slide as jobs data lifts tech — what COHR traders watch next
10 January 2026
1 min read

Coherent stock snaps back after steep slide as jobs data lifts tech — what COHR traders watch next

NEW YORK, January 9, 2026, 20:55 EST — Market closed

  • Coherent shares closed up 2.8% on Friday, a day after a near-10% drop
  • A broad tech bid followed a softer U.S. jobs report, shifting rate expectations
  • Focus turns to U.S. CPI on Jan. 13 and Coherent’s next earnings window in early February

Coherent Corp. shares closed up 2.84% at $178.06 on Friday, clawing back some ground a day after the stock slid 9.64% in a sharp reversal that jolted the week’s highfliers. The stock traded between $167.50 and $181.55 in the session, with volume of about 5.46 million shares.

The whipsaw matters because Coherent sits in the AI-linked hardware chain and tends to move with shifts in risk appetite and rate bets, especially when the Nasdaq is pressing highs. The S&P 500 ended Friday up 0.6% and the Nasdaq Composite gained 0.8% after the jobs data, according to MarketWatch.

U.S. payrolls rose by 50,000 in December and the unemployment rate dipped to 4.4%, while wage growth stayed firm, Reuters reported — a mix that economists said should keep the Federal Reserve cautious. “Hiring is still stuck in stall speed,” Fitch Ratings economist Olu Sonola said in comments carried by Reuters, even as the jobless rate eased. Reuters

For Coherent, the next clean read will be earnings and guidance — not the tape. In its last results release, the company projected fiscal second-quarter revenue of $1.56 billion to $1.70 billion and non-GAAP earnings per share of $1.10 to $1.30; non-GAAP strips out certain items such as acquisition-related charges and other adjustments. CEO Jim Anderson said then growth was driven by “strong demand from AI-related datacenters and communications,” while the company expanded capacity.

Optical-component peers were also higher into the close, though Coherent’s move was larger. Lumentum, Fabrinet and IPG Photonics were last up about 0.9%, 1.0% and 0.6%, respectively, according to market data.

But the stock’s valuation leaves little room for a stumble. AAII data put Coherent’s price-to-earnings ratio at about 227.5, far above the industry median it cited, and flagged the name as “Ultra Expensive,” even after the week’s pullback. aaii.com

The next catalysts are mostly macro at first: U.S. CPI is due on Jan. 13 and investors are also watching the Fed’s Jan. 27-28 meeting for any shift in messaging on rates. On the company side, earnings calendars including Zacks and StockAnalysis.com list Coherent’s next report date around Feb. 4, though such dates can change before a company confirms them.

Stock Market Today

  • PureTech's Spin-Out Seaport Therapeutics Prices $254.9 Million Nasdaq IPO
    May 1, 2026, 4:32 AM EDT. PureTech Health's spin-out, Seaport Therapeutics, priced its upsized Nasdaq IPO at $18 per share, raising approximately $254.9 million before fees. The clinical-stage biotech, focused on oral therapies for neuropsychiatric conditions like depression and anxiety, will begin trading under ticker SPTX on May 1. Major banks including Goldman Sachs and J.P. Morgan backed the offering, reflecting strong investor appetite in neuropsychiatry-focused biotech. PureTech will retain over 16.6 million shares post-IPO, reinforcing its hub-and-spoke model for creating new medicines. While PureTech shows solid liquidity and promising clinical progress, it faces ongoing profitability and funding risks as it advances its pipeline.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 01.05.2026

1 May 2026
LIVEMarkets rolling coverageStarted: May 1, 2026, 12:00 AM EDTUpdated: May 1, 2026, 4:32 AM EDT PureTech's Spin-Out Seaport Therapeutics Prices $254.9 Million Nasdaq IPO May 1, 2026, 4:32 AM EDT. PureTech Health's spin-out, Seaport Therapeutics, priced its upsized Nasdaq IPO at $18 per share, raising approximately $254.9 million before fees. The clinical-stage biotech, focused on oral therapies for neuropsychiatric conditions like depression and anxiety, will begin trading under ticker SPTX on May 1. Major banks including Goldman Sachs and J.P. Morgan backed the offering, reflecting strong investor appetite in neuropsychiatry-focused biotech. PureTech will retain over 16.6 million shares post-IPO, reinforcing
Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Ondas (ONDS) stock slips after hours after $1B share-and-warrant deal — what to know next week
Previous Story

Ondas (ONDS) stock slips after hours after $1B share-and-warrant deal — what to know next week

DroneShield stock to watch after JPMorgan crosses 5% line; ASX:DRO ends week above A$4
Next Story

DroneShield stock to watch after JPMorgan crosses 5% line; ASX:DRO ends week above A$4

Go toTop